340bemployed.org

Your Free Source for 340B News and Commentary

  • Home
  • About Us
  • Employers
  • Job Seekers
  • Advertise
  • 340B Health

Senate Reform Bill Retains Critical Inpatient Language

A proposal to extend the 340B discount to the hospital inpatient setting survived the latest Senate health care reform bill. But the game isn't over.
 

Print Article

Photo of a doctor.December 1 , 2009 – The latest health care reform bill unveiled by the Senate leadership brought some welcome news to 340B hospitals who had been riding a roller-coaster in recent months as their key legislative proposals were tossed in and out of different versions of the reform bill.

The new legislation, expected to be considered by the full Senate in early December, retained the reform provisions that 340B hospitals had pushed for, including the all-important extension of the 340B drug discount program to the hospital inpatient setting.December 1 , 2009 – The latest health care reform bill unveiled by the Senate leadership brought some welcome news to 340B hospitals who had been riding a roller-coaster in recent months as their key legislative proposals were tossed in and out of different versions of the reform bill.

The House bill passed Nov. 7 was stripped of that language, upsetting financially pressured safety-net providers who would stand to gain millions of dollars in savings with the extended discount.

The Senate bill also makes freestanding children’s and cancer hospitals, and certain rural hospitals, eligible to join the 340B program, and creates new rules and guidelines to ensure the integrity of the program.

“We’re extremely pleased,” said Robert Whitler, vice president of government and community affairs at Charleston Area Medical Center, a tertiary care safety-net hospital serving southern and central West Virginia. “The extension of 340B discounts in inpatient drugs will save our hospital an estimated $5 million to $7 million annually, and this additional cost saving is critical. It allows us to continue our safety-net mission here.”

Whitler’s hospital picks up one-quarter of the acute hospital charity care in West Virginia, a state where more than 21 percent of adults lack health insurance, according to the Kaiser Family Foundation. It’s a constant struggle to meet the needs of patients, Whitler said.

Bill expands, strengthens 340B program

During a rare Saturday session Nov. 21, the Senate overcame an important hurdle in its effort to enact health reform, passing a measure that allows the legislation to be considered on the Senate floor.

The motion, called a “cloture vote”, required the support of three-fifths of senators and passed by a party-line vote of 60 to 39 — without a single vote to spare for the Democrats pushing for the bill. The Senate was set to begin its consideration of the health care reform bill on Nov. 30.

Along with the 340B inpatient language and the provisions extending the 340B discount to new covered entities, the current Senate bill would lower the threshold for sole community hospitals and rural referral hospitals interested in joining the program. Today, sole community hospitals and rural referral hospitals must meet a disproportionate-share (DSH) adjustment percentage of 11.75 percent. The Senate bill proposes to drop the DSH adjustment down to 8 percent.

Rural hospitals advocates have argued that while their facilities may not serve as many Medicaid patients as urban hospitals, they’re often the only hospital within a large geographic area.

The legislation would require the government to post 340B prices on a password-protected Web site and, for the first time, impose sanctions on drug manufacturers and covered entities that violate 340B program rules. The dispute resolution process managed by the U.S. Health Resources Services Administration (HRSA) would also be strengthened. The goal of this provision is to ensure that HRSA acts on disagreements between manufacturers and covered entities in a timely manner.

The Senate bill would also require 340B-covered entities to update their contact information on the Office of Pharmacy Affairs’ Web site at least once a year.

Congress faces tight deadlines before 2010 election year

Other 340B Measures in the Senate bill
  • Allows hospitals to purchase outpatient drugs not available at a 340B price from group purchasing organizations (GPOs).
  • Increases the Medicaid rebate to 23.1 percent of average manufacturer price — which should result in significantly higher discounts for 340B providers since the 340B program uses a similar discount methodology.
  • Exempts 340B providers from having to bill Medicaid managed care plans at acquisition cost.
  • Provides relief to seniors in the Medicare Part D coverage gap or donut hole.

Lawmakers want to avoid dragging the controversial reform debate into next year’s congressional re-election campaigns. So congressional leaders hope to vote on the final health care reform bill before the end of the year.

After the Senate passage, the House can either adopt the Senate health care reform bill and send it on to the White House for the president’s signature — or choose to negotiate with the Senate to reconcile the differences between that legislation and the bill the House passed early November. If House and Senate negotiations produce a new health bill, it must be passed by both houses of Congress before being signed into law by the president, a process certain to delay things.

When the full Senate considers the health reform bill in early December, lawmakers will have the opportunity to amend and change anything in the bill. This fact has intensified advocacy from virtually all groups with a stake in the legislation, including the 340B community.

During the Senate Health, Education, Labor & Pensions Committee’s consideration of the bill in July, two lawmakers proposed amendments that would have stripped the 340B inpatient extension from the bill. One lawmaker even recommended sunsetting the program altogether for many 340B providers if the number of uninsured were to drop significantly.

While these amendments received a lot of attention when first drafted, they were dropped before the committee had a chance to vote on the bill.

Follow us on X

340B Health Follow

340B Health is the leading advocate & resource for hospitals that serve their communities by participating in the 340B drug pricing program. #Protect340B

340BHealth
340bhealth 340B Health @340bhealth ·
14 May

Do you know why certain medications are sometimes sold to #340B covered entities for as low as one penny?
It’s not because covered entities are gaming the system—it’s to put a check on pharmaceutical price increases. Those penny-priced drugs are the result of penalties Congress…

Reply on Twitter 1922677172184957109 Retweet on Twitter 1922677172184957109 Like on Twitter 1922677172184957109 Twitter 1922677172184957109
340bhealth 340B Health @340bhealth ·
13 May

We invited our President and CEO @MaureenTestoni onto #340BInsight for help understanding the litigation around #340B rebate models and potential federal regulatory shifts ahead for 340B. We also discuss how states are responding to the pharmaceutical industry’s efforts to shrink…

Reply on Twitter 1922322756617564612 Retweet on Twitter 1922322756617564612 Like on Twitter 1922322756617564612 Twitter 1922322756617564612
340bhealth 340B Health @340bhealth ·
12 May

This #NationalHospitalWeek, we recognize the safety-net providers who make health care possible for communities that need it most. #Becauseof340B, tens of millions of Americans throughout the U.S. have better access to life-saving care and medicines at no cost to taxpayers.…

Reply on Twitter 1921912167135101033 Retweet on Twitter 1921912167135101033 Like on Twitter 1921912167135101033 Twitter 1921912167135101033
Load More

RSS 340B Informed

  • An In-Depth Look at Total 340B Purchases
  • Ideas for 340B Changes Could Lead to Legislation
  • Help From 340B After a Rare Diagnosis and an Unaffordable Bill

Copyright © 2025 · 340B Health